Sign up to view this video Join Now Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Leveraging Patient Advocacy To Scale Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned Solutions for Trial Design Challenges in Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2
Sign up to view this video Join Now Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Leveraging Patient Advocacy To Scale Rare Disease Trials Case Studies in Rare Disease Commercialization: Lessons Learned Solutions for Trial Design Challenges in Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2
